Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth

dc.contributor.authorMathis, Noah J.
dc.contributor.authorAdaniya, Emily N.
dc.contributor.authorSmith, Lauren M.
dc.contributor.authorRobling, Alexander G.
dc.contributor.authorJepsen, Karl J.
dc.contributor.authorSchlecht, Stephen H.
dc.contributor.departmentAnatomy and Cell Biology, IU School of Medicineen_US
dc.date.accessioned2019-08-08T16:10:13Z
dc.date.available2019-08-08T16:10:13Z
dc.date.issued2019-04-04
dc.description.abstractAdministration of sclerostin-neutralizing antibody (Scl-Ab) treatment has been shown to elicit an anabolic bone response in growing and adult mice. Prior work characterized the response of individual mouse strains but did not establish whether the impact of Scl-Ab on whole bone strength would vary across different inbred mouse strains. Herein, we tested the hypothesis that two inbred mouse strains (A/J and C57BL/6J (B6)) will show different whole bone strength outcomes following sclerostin-neutralizing antibody (Scl-Ab) treatment during growth (4.5-8.5 weeks of age). Treated B6 femurs showed a significantly greater stiffness (S) (68.8% vs. 46.0%) and maximum load (ML) (84.7% vs. 44.8%) compared to A/J. Although treated A/J and B6 femurs showed greater cortical area (Ct.Ar) similarly relative to their controls (37.7% in A/J and 41.1% in B6), the location of new bone deposition responsible for the greater mass differed between strains and may explain the greater whole bone strength observed in treated B6 mice. A/J femurs showed periosteal expansion and endocortical infilling, while B6 femurs showed periosteal expansion. Post-yield displacement (PYD) was smaller in treated A/J femurs (-61.2%, p < 0.001) resulting in greater brittleness compared to controls; an effect not present in B6 mice. Inter-strain differences in S, ML, and PYD led to divergent changes in work-to-fracture (Work). Work was 27.2% (p = 0.366) lower in treated A/J mice and 66.2% (p < 0.001) greater in treated B6 mice relative to controls. Our data confirmed the anabolic response to Scl-Ab shown by others, and provided evidence suggesting the mechanical benefits of Scl-Ab administration may be modulated by genetic background, with intrinsic growth patterns of these mice guiding the location of new bone deposition. Whether these differential outcomes will persist in adult and elderly mice remains to be determined.en_US
dc.identifier.citationMathis, N. J., Adaniya, E. N., Smith, L. M., Robling, A. G., Jepsen, K. J., & Schlecht, S. H. (2019). Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth. PloS one, 14(4), e0214520. doi:10.1371/journal.pone.0214520en_US
dc.identifier.urihttps://hdl.handle.net/1805/20248
dc.language.isoen_USen_US
dc.publisherPLOSen_US
dc.relation.isversionof10.1371/journal.pone.0214520en_US
dc.relation.journalPlos Oneen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/us*
dc.sourcePMCen_US
dc.subjectSclerostin-neutralizing antibody (Scl-Ab)en_US
dc.subjectAnabolic bone responseen_US
dc.subjectBone strengthen_US
dc.subjectA/J femursen_US
dc.subjectB6 femursen_US
dc.subjectPost-yield displacement (PYD)en_US
dc.titleDifferential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growthen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pone.0214520.pdf
Size:
2.05 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: